UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 170 filers reported holding UNIQURE NV in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,548,190 | -78.1% | 379,760 | -62.6% | 0.00% | -80.0% |
| Q2 2023 | $11,639,945 | +165593.2% | 1,015,702 | +191.2% | 0.01% | +25.0% |
| Q1 2023 | $7,025 | -58.6% | 348,826 | -53.4% | 0.00% | -55.6% |
| Q4 2022 | $16,959 | -99.3% | 748,060 | +474.9% | 0.01% | +350.0% |
| Q2 2022 | $2,425,000 | -40.0% | 130,115 | -41.8% | 0.00% | 0.0% |
| Q1 2022 | $4,042,000 | -50.5% | 223,688 | -43.2% | 0.00% | -50.0% |
| Q4 2021 | $8,165,000 | +970.1% | 393,671 | +1489.1% | 0.00% | – |
| Q2 2021 | $763,000 | -92.8% | 24,773 | -92.1% | 0.00% | -100.0% |
| Q1 2021 | $10,552,000 | -23.9% | 313,195 | -18.4% | 0.01% | -20.0% |
| Q4 2020 | $13,865,000 | +1858.3% | 383,750 | +1896.5% | 0.01% | +900.0% |
| Q3 2020 | $708,000 | -94.2% | 19,221 | -92.9% | 0.00% | -94.1% |
| Q2 2020 | $12,199,000 | +5047.3% | 270,726 | +5314.5% | 0.02% | +1600.0% |
| Q1 2020 | $237,000 | -99.1% | 5,000 | -98.6% | 0.00% | -96.9% |
| Q4 2019 | $25,837,000 | +278.1% | 360,548 | +107.6% | 0.03% | +190.9% |
| Q3 2019 | $6,834,000 | -89.8% | 173,653 | -79.7% | 0.01% | -89.0% |
| Q2 2019 | $66,694,000 | +136.1% | 853,414 | +80.2% | 0.10% | +138.1% |
| Q1 2019 | $28,253,000 | +6.9% | 473,640 | -48.3% | 0.04% | +5.0% |
| Q4 2018 | $26,420,000 | +19.2% | 916,698 | +50.6% | 0.04% | +48.1% |
| Q3 2018 | $22,156,000 | -12.0% | 608,825 | -8.6% | 0.03% | -18.2% |
| Q2 2018 | $25,181,000 | +41.1% | 666,171 | -12.3% | 0.03% | +37.5% |
| Q1 2018 | $17,850,000 | +311.3% | 759,585 | +242.8% | 0.02% | +300.0% |
| Q4 2017 | $4,340,000 | +52.4% | 221,554 | -25.3% | 0.01% | +50.0% |
| Q3 2017 | $2,847,000 | +318.7% | 296,568 | +169.8% | 0.00% | +300.0% |
| Q2 2017 | $680,000 | -52.8% | 109,935 | -55.9% | 0.00% | -66.7% |
| Q1 2017 | $1,442,000 | -57.5% | 249,501 | -58.8% | 0.00% | -57.1% |
| Q4 2016 | $3,394,000 | +4039.0% | 606,142 | +5587.7% | 0.01% | – |
| Q3 2016 | $82,000 | -53.9% | 10,657 | -55.9% | 0.00% | – |
| Q2 2016 | $178,000 | -75.1% | 24,139 | -60.0% | 0.00% | -100.0% |
| Q1 2016 | $716,000 | -85.7% | 60,285 | -80.1% | 0.00% | -81.8% |
| Q4 2015 | $5,010,000 | -46.1% | 302,913 | -33.3% | 0.01% | -38.9% |
| Q3 2015 | $9,287,000 | -0.9% | 454,117 | +30.9% | 0.02% | 0.0% |
| Q2 2015 | $9,370,000 | +97.3% | 347,037 | +77.7% | 0.02% | +100.0% |
| Q1 2015 | $4,748,000 | +122.4% | 195,248 | +35.4% | 0.01% | +80.0% |
| Q4 2014 | $2,135,000 | +90.3% | 144,151 | +18.8% | 0.01% | +66.7% |
| Q3 2014 | $1,122,000 | -21.5% | 121,305 | +15.3% | 0.00% | -25.0% |
| Q2 2014 | $1,430,000 | -47.3% | 105,242 | -39.6% | 0.00% | -50.0% |
| Q1 2014 | $2,715,000 | – | 174,243 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |